News Focus
News Focus
icon url

ApollyonZ

08/20/19 12:47 PM

#42210 RE: ApollyonZ #42049

$LAHO The Smart Money Is Piling Into Regenerative Medicine

Progressive Approval Could Be a Game Changer for RM
Investing in Regenerative Medicine


The Goldman report discusses Samumed, a private RM company. With $300 million in funding,it’s valued at a staggering $12 billion Samumed’s drug platform aims to regenerate various tissues such as bone, cartilage, hair, and skin.

https://www.forbes.com/sites/patrickcox/2017/04/14/smart-money-is-piling-into-regenerative-medicine/#293ec5585b6c

Connections : Goldman Sachs Group Inc
New York Stem Cell Foundation, Inc.

https://www.marketscreener.com/GOLDMAN-SACHS-GROUP-INC-12831/company/

Hedgefund Mesoblast!

https://whalewisdom.com/stock/mblty

Mesoblast
Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),

https://www.mesoblast.com/company/management-team




https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150605693

$LAHO TITANIC MARKET UPSIDE..NUMBER#1 GSCG